Dimensional Fund Advisors discloses equity positions across UK companies, emphasizing transparency in ownership and control structures.
US plans nuclear weapons testing amid global arms tensions, sparking debate and concern over potential consequences.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Dimensional Fund Advisors discloses equity positions across UK companies, emphasizing transparency in ownership and control structures.
US plans nuclear weapons testing amid global arms tensions, sparking debate and concern over potential consequences.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.